Navigation Links
Scientist Warns Industry Not to Ignore Potential Health Threat to Pharmacy Workers
Date:11/10/2008

- Recently issued study that found retail pharmacy workers are exposed to

airborne pharmaceutical agents needs further review -

DREXEL, Mo., Nov. 10 /PRNewswire/ -- AlburtyLab's President, David Alburty issued a statement today regarding serious concerns about efforts by McKesson/Parata to misrepresent and diminish the potential health threats that pharmacy workers face when they work in pharmacies using air pressure driven dispensing machines.

Statement by David Alburty:

Communications recently issued by McKesson/Parata regarding potential exposure of pharmacy workers to airborne pill dust when they use air pressure driven drug dispensing machines attempt to mask a potentially serious health matter affecting pharmacy workers.

McKesson/Parata claims that unreleased tests they performed, not conducted by Occupational Safety and Health Administration (OSHA) but "under OSHA standards (set by *1 NIOSH)," are relevant to this issue. They are not.

It is critical to know that OSHA air quality regulations are limited to general guidelines for "nuisance dust" such as emissions from grinding and burning processes. There are no OSHA standards establishing safe quantities of pharmaceutical compounds in the air. Nor are there OSHA standards for PM-2.5 particles and nanoparticles. These very small particles, which are used to transport pharmaceutical agents, have been shown to be generated when pills are subjected to air pressure dispensing.

PM-2.5 particles are the subject of EPA air quality standards and World Health Organization guidelines because they penetrate the lungs deeply and rapidly enter the bloodstream. As documented in our (AlburtyLab, October 2008) study, these particles are believed to cause a number of serious health problems. The fact that OSHA standards do not yet address this issue does not mean that it should be ignored.

Our study unveiled potentially serious exposures for pharmacy workers, and
'/>"/>

SOURCE AlburtyLab, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Paxonix Recognized for Exemplary Support in New Product Development and Implementation 2Health News:March of Dimes Seeks Answers to Preterm Birth 2Health News:InterComponentWare Inc. Aligns with the Center for Health Transformation 2Health News:InterComponentWare Inc. Aligns with the Center for Health Transformation 3Health News:InterComponentWare Inc. Aligns with the Center for Health Transformation 4Health News:Siemens Healthcare Kicks Off New Era of Expanded Access to High-Field MRI with First Install of Affordable MAGNETOM ESSENZA 2Health News:Siemens Healthcare Kicks Off New Era of Expanded Access to High-Field MRI with First Install of Affordable MAGNETOM ESSENZA 3Health News:Anthem Blue Cross and Blue Shield Expands Network of Hospitals to Serve Hoosier Healthwise Members 2Health News:Anthem Blue Cross and Blue Shield Expands Network of Hospitals to Serve Hoosier Healthwise Members 3Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 2Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 3Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 4Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 5Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 6Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 7Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 8Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 9
Breaking Medicine Technology:SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology 2SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology 3NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3House to Home Services is Selected as a Unique Health Provider 52220 1House to Home Services is Selected as a Unique Health Provider 52220 2Fast Growing National Health Company Has New Owners Big Growth Plans 52218 1Clinical Research Safety and Ethical Standards in Developing World Up to U S Levels Report Says 52216 1Clinical Research Safety and Ethical Standards in Developing World Up to U S Levels Report Says 52216 2Clinical Research Safety and Ethical Standards in Developing World Up to U S Levels Report Says 52216 3Clinical Research Safety and Ethical Standards in Developing World Up to U S Levels Report Says 52216 4Clinical Research Safety and Ethical Standards in Developing World Up to U S Levels Report Says 52216 5